DD vs. BMY
DD (DuPont de Nemours, Inc.) and BMY (Bristol-Myers Squibb Company) are both stocks. DD operates in Chemicals (Basic Materials), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, DD returned 9.17%/yr vs 0.73%/yr for BMY. At a 0.27 correlation, their price movements are largely independent.
Performance
DD vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DD achieves a 21.91% return, which is significantly higher than BMY's 8.27% return.
DD
- 1D
- 3.03%
- 1M
- -1.41%
- YTD
- 21.91%
- 6M
- 19.73%
- 1Y
- 77.05%
- 3Y*
- 20.30%
- 5Y*
- 9.17%
- 10Y*
- —
BMY
- 1D
- 0.40%
- 1M
- 0.23%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 20.57%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
DD vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
DD DuPont de Nemours, Inc. | 21.91% | 28.77% | 1.04% | 14.36% | -13.36% | 15.41% | 13.28% | -1.38% |
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 43.93% |
Correlation
The correlation between DD and BMY is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jun 3, 2019 | 0.27 |
Fundamentals
DD:
$19.92B
BMY:
$116.75B
DD:
-$0.10
BMY:
$3.57
DD:
2.07
BMY:
2.40
DD:
1.42
BMY:
5.82
DD:
$9.70B
BMY:
$48.48B
DD:
$2.68B
BMY:
$33.33B
DD:
$1.54B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DD vs. BMY — Risk / Return Rank
DD
BMY
DD vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DuPont de Nemours, Inc. (DD) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DD | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.67 | ||
| Sortino ratioReturn per unit of downside risk | +2.06 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.14 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 4.24 | 1.53 | +2.71 |
| Martin ratioReturn relative to average drawdown | 13.16 | 3.32 | +9.84 |
Loading charts...
Drawdowns
DD vs. BMY - Drawdown Comparison
The maximum DD drawdown since its inception was -62.03%, smaller than the maximum BMY drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for DD and BMY.
Loading charts...
Drawdown Indicators
| DD | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.03% | -72.03% | +10.00% |
Max Drawdown (1Y)Largest decline over 1 year | -17.31% | -12.05% | -5.26% |
Max Drawdown (3Y)Largest decline over 3 years | -37.84% | -36.85% | -0.99% |
Max Drawdown (5Y)Largest decline over 5 years | -40.22% | -47.67% | +7.45% |
Max Drawdown (10Y)Largest decline over 10 years | — | -47.67% | — |
Current DrawdownCurrent decline from peak | -4.90% | -17.79% | +12.89% |
Average DrawdownAverage peak-to-trough decline | -14.56% | -22.38% | +7.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.57% | 6.34% | -0.77% |
Volatility
DD vs. BMY - Volatility Comparison
DuPont de Nemours, Inc. (DD) has a higher volatility of 10.87% compared to Bristol-Myers Squibb Company (BMY) at 8.22%. This indicates that DD's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DD | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.87% | 8.22% | +2.65% |
Volatility (6M)Calculated over the trailing 6-month period | 23.72% | 18.18% | +5.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.19% | 27.08% | +4.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.07% | 24.02% | +6.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.33% | 25.29% | +9.04% |
Dividends
DD vs. BMY - Dividend Comparison
DD's dividend yield for the trailing twelve months is around 101.24%, more than BMY's 4.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
DD DuPont de Nemours, Inc. | 101.24% | 121.72% | 1.99% | 1.87% | 1.92% | 1.49% | 1.69% | 0.93% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
DD vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between DuPont de Nemours, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DD vs. BMY - Profitability Comparison
DD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DuPont de Nemours, Inc. reported a gross profit of 0.00 and revenue of 1.68B. Therefore, the gross margin over that period was 0.0%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
DD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DuPont de Nemours, Inc. reported an operating income of 14.00M and revenue of 1.68B, resulting in an operating margin of 0.8%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
DD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DuPont de Nemours, Inc. reported a net income of 150.00M and revenue of 1.68B, resulting in a net margin of 8.9%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
DD and BMY have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DD has higher volatility (10.87%) compared to BMY (8.22%). In terms of maximum drawdown, DD dropped -62.03% vs BMY's -72.03%.
DD currently has the higher Sharpe Ratio (2.36 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DD and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer